NAD+ Injection Guide — Protocols, Dosing, and Safety

NAD+ Injection Guide — Protocols, Dosing, and Safety

A 2022 metabolic study published by researchers at Brigham and Women's Hospital found that NAD+ levels decline by approximately 50% between ages 40 and 60. A reduction directly correlated with mitochondrial dysfunction, impaired DNA repair, and accelerated cellular aging. What most patients don't realize: oral NAD+ supplements cannot reverse this decline because the molecule is too large and unstable to survive gastric acid and first-pass hepatic metabolism intact.

Our team has worked with hundreds of patients navigating NAD+ therapy protocols. The administration method. Oral versus injectable. Determines everything. Injections bypass the digestive barrier entirely, delivering nicotinamide adenine dinucleotide directly into muscle tissue where it enters systemic circulation within minutes at bioavailability rates exceeding 90%. The protocols, reconstitution techniques, and injection site selection described in this guide reflect the clinical standards we've observed across functional medicine practices and longevity clinics nationwide.

What is NAD+ injection therapy and how does it work?

NAD+ injection therapy delivers nicotinamide adenine dinucleotide. A coenzyme required for mitochondrial ATP synthesis, DNA repair enzyme activation, and sirtuin-mediated cellular maintenance. Via intramuscular or subcutaneous administration. The injection route achieves plasma NAD+ concentrations 15–20 times higher than oral supplementation because the molecule enters circulation without hepatic degradation. Research conducted at Washington University School of Medicine demonstrated that intramuscular NAD+ administration produced measurable increases in cellular NAD+ levels within 30 minutes, sustained for 4–6 hours post-injection.

The confusion around NAD+ supplementation stems from one critical misunderstanding: NAD+ is not absorbed intact through the gut. Oral NAD+ breaks down into nicotinamide riboside (NR) or nicotinic acid during digestion. Precursors that must be reassembled into NAD+ through the salvage pathway, a multi-step enzymatic process that loses 70–85% of the original dose. Injectable NAD+ skips this entirely. The coenzyme reaches tissues in its active form, binding immediately to NAD-dependent enzymes without requiring metabolic conversion. This article covers reconstitution protocols for lyophilized NAD+, dosing frameworks used in clinical settings, injection site selection and technique, expected timelines for subjective and measurable effects, and the critical storage mistakes that render expensive vials therapeutically useless.

NAD+ Injection Reconstitution and Storage Protocol

Lyophilized NAD+ powder arrives as a freeze-dried white crystalline substance stored in sterile vials. Typically 100mg, 250mg, or 500mg per vial depending on supplier. Reconstitution means dissolving this powder in bacteriostatic water (0.9% benzyl alcohol) to create an injectable solution. The process is straightforward but intolerant of contamination or temperature abuse.

Withdraw the appropriate volume of bacteriostatic water using a sterile syringe. Most protocols use 2mL of water per 100mg of NAD+ powder, yielding a 50mg/mL concentration. Inject the water slowly down the inside wall of the vial rather than directly onto the powder. This prevents foaming and protein denaturation. Gently swirl the vial in a circular motion until the powder fully dissolves into a clear solution. Do not shake the vial. Vigorous agitation damages the NAD+ molecular structure and reduces potency measurably.

Once reconstituted, NAD+ solution must be refrigerated at 2–8°C (36–46°F) and used within 30 days. Any temperature excursion above 8°C begins irreversible degradation. The coenzyme oxidizes into inactive metabolites that neither home testing nor visual inspection can detect. Store reconstituted vials in the main refrigerator compartment, not the door (which experiences temperature fluctuations every time the fridge opens). Unreconstituted lyophilized powder remains stable at room temperature in its sealed vial for 12–24 months, but once mixed with bacteriostatic water, the 30-day clock starts immediately.

Our experience with patients shows the most common error isn't contamination. It's assuming refrigeration is optional. NAD+ oxidizes rapidly at ambient temperature. A vial left on the counter overnight loses 40–60% potency by morning.

NAD+ Injection Dosing Frameworks and Administration Frequency

Clinical NAD+ injection protocols range from 50mg to 500mg per dose depending on treatment goals. Cellular maintenance versus acute metabolic support. Most functional medicine practitioners start patients at 100–250mg administered intramuscularly twice weekly, then adjust based on subjective energy response and objective biomarkers (plasma NAD+/NADH ratio, ATP production assays).

Intramuscular (IM) injection delivers NAD+ into the deltoid, vastus lateralis (outer thigh), or ventrogluteal muscle using a 1-inch 23-gauge or 25-gauge needle. The solution absorbs into capillary beds within the muscle tissue and enters systemic circulation within 15–30 minutes. Subcutaneous (SubQ) injection. Into the fatty tissue of the abdomen or outer thigh using a shorter 5/8-inch needle. Absorbs more slowly but causes less post-injection soreness. Absorption kinetics differ: IM peaks faster but clears within 4–6 hours; SubQ sustains lower plasma levels for 6–8 hours.

A 2021 study published in Aging Cell used 250mg intramuscular NAD+ twice weekly for 12 weeks in adults aged 55–79 and measured statistically significant improvements in skeletal muscle NAD+ content (increased by 1.3-fold from baseline) and mitochondrial respiratory capacity. Higher doses (500mg+) are used in acute settings. Post-surgical recovery, neurological injury, severe chronic fatigue. But require medical supervision due to transient vasodilation and flushing that can occur at doses above 300mg.

The protocol TrimRx patients follow mirrors this structure: initial loading phase of 250mg twice weekly for 4 weeks, followed by maintenance at 100–200mg weekly or biweekly depending on metabolic demand and patient-reported energy stability. There is no universal 'correct' dose. NAD+ requirements scale with mitochondrial turnover rate, which varies based on age, activity level, and baseline metabolic health.

Injection Site Selection and Technique

Proper injection technique determines both safety and absorption efficiency. Intramuscular NAD+ should be administered into a large muscle group with adequate blood flow. The deltoid (shoulder), vastus lateralis (outer thigh), or ventrogluteal (hip) are standard sites. Rotate injection sites with each dose to prevent tissue irritation and lipohypertrophy (localized fat buildup caused by repeated injections in the same spot).

Clean the injection site with an alcohol swab and allow it to dry completely. Injecting through wet alcohol introduces contamination risk and causes stinging. Hold the syringe like a dart at a 90-degree angle to the skin surface. Insert the needle swiftly in one smooth motion, then aspirate (pull back slightly on the plunger) to confirm the needle isn't in a vein. If blood appears, withdraw and reposition. Inject the NAD+ solution slowly over 10–15 seconds. Rapid injection causes localized pressure and post-injection soreness.

Subcutaneous injection technique differs: pinch a fold of skin on the abdomen (at least 2 inches from the navel) or outer thigh, insert the needle at a 45-degree angle into the fatty tissue, and inject slowly. SubQ injections sting less during administration but may cause a small raised bump that resolves within 20–30 minutes as the solution absorbs.

The single biggest injection error we see: patients attempting to self-inject into the glute without proper visualization or assistance. The dorsogluteal site (upper outer quadrant of the buttock) carries sciatic nerve injury risk if the injection lands too low or medial. The ventrogluteal site (hip, just below the iliac crest) is anatomically safer and accessible for self-administration when standing in front of a mirror.

NAD+ Injection Guide: Full Comparison Table

Key Takeaways

• NAD+ injections deliver nicotinamide adenine dinucleotide directly into muscle or subcutaneous tissue at 90–95% bioavailability, bypassing the digestive degradation that limits oral supplements to 5–15% absorption.
• Reconstituted NAD+ solution must be refrigerated at 2–8°C and used within 30 days. Temperature excursions above 8°C cause irreversible oxidation and potency loss.
• Standard clinical protocols use 100–250mg intramuscular or subcutaneous injection twice weekly during loading phases, transitioning to weekly or biweekly maintenance dosing based on patient response.
• Intramuscular injection (deltoid, vastus lateralis, ventrogluteal) achieves faster plasma peak concentrations but causes more post-injection soreness than subcutaneous administration.
• Injection site rotation is mandatory to prevent tissue irritation and lipohypertrophy. Never inject into the same site more than once weekly.
• Research from Washington University demonstrated measurable increases in cellular NAD+ levels within 30 minutes of intramuscular administration, sustained for 4–6 hours.

What If: NAD+ Injection Scenarios

What If I Experience Flushing or Warmth After Injecting NAD+?

Inject 50–100mg less next time and slow your injection speed to 20–30 seconds instead of 10–15 seconds. Flushing results from transient vasodilation caused by rapid NAD+-induced nitric oxide release. It's harmless but uncomfortable. The sensation peaks 5–10 minutes post-injection and resolves within 30–45 minutes. Patients sensitive to flushing tolerate subcutaneous administration better than intramuscular because SubQ absorption is slower and produces lower peak plasma concentrations. Preloading with 500mg niacin (nicotinic acid) 30 minutes before NAD+ injection can paradoxically reduce flushing intensity by desensitizing histamine receptors, though this requires prescriber consultation.

What If I Accidentally Left My Reconstituted NAD+ Out of the Fridge Overnight?

Discard the vial and reconstitute a fresh one. NAD+ oxidizes rapidly at room temperature. A vial left out for 8–12 hours loses 40–60% potency even if it still appears clear and colorless. There is no reliable home test for NAD+ concentration post-degradation. The financial loss of one vial is trivial compared to injecting an inactive solution and assuming it 'didn't work' when cellular NAD+ remains depleted. Store backup unreconstituted powder at room temperature so temperature failures don't interrupt your protocol.

What If I Don't Feel Any Subjective Energy Change After Two Weeks of Injections?

Increase your dose to 250–300mg per injection or shift from once-weekly to twice-weekly administration. Subjective energy improvements correlate with baseline NAD+ depletion severity. Patients with severe chronic fatigue or mitochondrial dysfunction often require 4–6 weeks at therapeutic doses before noticing mental clarity or physical stamina changes. Objective biomarkers (plasma NAD+/NADH ratio, whole blood ATP levels) respond faster than subjective symptoms. If you've been injecting correctly and still notice no change after 6 weeks at 250mg twice weekly, consider whether your reconstituted solution was stored improperly or whether your baseline NAD+ status is less depleted than assumed.

The Clinical Truth About NAD+ Supplementation

Here's the honest answer: NAD+ pills are a waste of money if your goal is cellular NAD+ restoration. Not 'less effective than injections'. Genuinely ineffective for the marketed purpose. The NAD+ molecule is too large (663.43 g/mol) and too unstable to survive gastric pH intact. What reaches your bloodstream after swallowing an NAD+ capsule is nicotinamide or nicotinamide riboside. Precursors that must be enzymatically reassembled into NAD+ via the salvage pathway. That process loses 70–85% of the dose to hepatic metabolism and renal clearance before any NAD+ appears in peripheral tissues.

Injection is not 'better'. It's the only route that delivers NAD+ as NAD+. The coenzyme enters muscle tissue directly, binds to mitochondrial enzymes within minutes, and elevates cellular NAD+ concentrations measurably and reproducibly. Every other administration route is delivering NAD+ precursors, not NAD+ itself. The semantics matter because marketing has blurred the line between 'boosts NAD+ levels' (precursors might do this slowly and incompletely) and 'delivers NAD+ to cells' (only injection does this).

If your budget allows only oral supplementation, use nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN). Both are NAD+ precursors with better oral bioavailability than NAD+ itself. But understand what you're buying: a substrate that might increase NAD+ synthesis if your salvage pathway is functioning optimally, not direct NAD+ replacement. The clinical data supporting anti-aging and neuroprotective benefits comes almost exclusively from studies using injectable or intravenous NAD+, not oral formulations.

NAD+ injections work because they restore the coenzyme where it's needed. Inside mitochondria, binding to sirtuins, activating PARP enzymes that repair DNA strand breaks. Pills can't do that. The injection learning curve is 15 minutes. The difference in outcome is measurable.

If NAD+ restoration matters to your metabolic health, commit to learning proper injection technique or work with a provider who offers supervised IM administration. The powder, bacteriostatic water, syringes, and alcohol swabs cost less per month than most people spend on ineffective oral longevity supplements. TrimRx patients who transition from oral NMN to biweekly 250mg NAD+ injections report the difference within three weeks. Not placebo, not coincidence, but the gap between supplementing a precursor and replacing the coenzyme directly. The protocol works if you follow it correctly. The storage, reconstitution, and injection details in this guide aren't optional refinements. They're the difference between therapeutic success and expensive failure.